Anthony A. Florence Jr. - Jun 28, 2021 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
10%+ Owner
Signature
/s/ Sasha Keough, attorney-in-fact
Stock symbol
GLUE
Transactions as of
Jun 28, 2021
Transactions value $
$19,950,000
Form type
4
Date filed
6/30/2021, 06:02 PM
Previous filing
Jun 24, 2021
Next filing
Jul 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLUE Common Stock Conversion of derivative security +2.72M 2.72M Jun 28, 2021 See Note 2 F1, F2
transaction GLUE Common Stock Conversion of derivative security +3.26M +119.93% 5.97M Jun 28, 2021 See Note 2 F1, F2
transaction GLUE Common Stock Conversion of derivative security +669K +11.2% 6.64M Jun 28, 2021 See Note 2 F1, F2
transaction GLUE Common Stock Purchase $20M +1.05M +15.81% $19.00 7.69M Jun 28, 2021 See Note 2 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Series A-2 convertible preferred stock Conversion of derivative security -9.59M -100% 0 Jun 28, 2021 Common Stock 2.72M See Note 2 F1, F2
transaction GLUE Series B convertible preferred stock Conversion of derivative security -11.5M -100% 0 Jun 28, 2021 Common Stock 3.26M See Note 2 F1, F2
transaction GLUE Series C convertible preferred Stock Conversion of derivative security -2.36M -100% 0 Jun 28, 2021 Common Stock 669K See Note 2 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date.
F2 The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.